As a mature category, analgesics faces the prospect of stagnant value sales over the forecast period, in real terms. Analgesics are widely used in society and there is little scope to expand usage.
Combined products – analgesics offer solid growth opportunities to manufacturers, since this category is still underdeveloped when compared to other European countries. Adult combination products together with Diclofenac and topical analgesics present the best future growth opportunities, due to the wide spectrum of treatments possible with these products.
Despite the limited presence of generics in OTC analgesics compared to Rx, sales of OTC generics are growing well. There has been a visible acceleration in sales of OTC generic analgesics over 2023 and 2024 due to rising prices and the high cost of living.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in Portugal with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Portugal, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See All of Our DefinitionsThis report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!